Chen Schor Adicet Bio, Inc. (ACET) insider trading activity

Chen Schor is President & CEO of Adicet Bio, Inc.. Currently has a direct ownership of 137,201 shares of ACET, which is worth approximately $138,573. The most recent transaction as insider was on Jan 24, 2025, when has been sold 28,101 shares (Common Stock) at a price of $0.92 per share, resulting in proceeds of $25,852. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K

0.92% 3M change

0.92% 12M change

Total Value Held $138,573

Chen Schor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 24 2025	SELL Payment of exercise price or tax liability	$25,852 $0.92 p/Share	28,101 Reduced 17.0%	137,201 Common Stock
Jan 24 2024	SELL Payment of exercise price or tax liability	$36,696 $2.4 p/Share	15,290 Reduced 9.94%	138,471 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	70,300 Added 25.19%	208,771 Common Stock
Oct 02 2023	SELL Payment of exercise price or tax liability	$31,794 $1.37 p/Share	23,208 Reduced 13.11%	153,761 Common Stock
Sep 29 2023	SELL Open market or private sale	$7,480 $1.36 p/Share	5,500 Reduced 3.01%	176,969 Common Stock
Sep 28 2023	BUY Open market or private purchase	$7,810 $1.42 p/Share	5,500 Added 2.93%	182,469 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	85,500 Added 32.58%	176,969 Common Stock
Nov 10 2022	SELL Open market or private sale	$209,353 $21.03 p/Share	9,955 Reduced 9.82%	91,469 Common Stock
Oct 04 2022	SELL Payment of exercise price or tax liability	$302,715 $14.22 p/Share	21,288 Reduced 17.35%	101,424 Common Stock
Aug 04 2022	SELL Payment of exercise price or tax liability	$388,506 $18.25 p/Share	21,288 Reduced 14.78%	122,712 Common Stock
Aug 04 2022	BUY Grant, award, or other acquisition	-	48,000 Added 25.0%	144,000 Common Stock
Jul 06 2022	SELL Bona fide gift	-	53,424 Reduced 35.75%	96,000 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$303,780 $14.27 p/Share	21,288 Reduced 12.47%	149,424 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	48,000 Added 21.95%	170,712 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$248,857 $11.69 p/Share	21,288 Reduced 14.78%	122,712 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	48,000 Added 25.0%	144,000 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	240,000 Added 50.0%	240,000 Common Stock
Oct 23 2020	SELL Payment of exercise price or tax liability	-	8,649 Reduced 10.66%	72,499 Common Stock

Also insider at

KPTI

Karyopharm Therapeutics Inc. Healthcare

Chen Schor

President & CEO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACET shares.

Notify only if

Value

Insider Trading

Get notified when an Adicet Bio, Inc. insider buys or sells ACET shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adicet Bio, Inc.

Track Activities on ACET

Account